Results 111 to 120 of about 13,293 (292)

Applications of fractional calculus to epidemiological models

open access: yes, 2012
Epidemiological spreading does not only happen from person to neighbouring person but often over wide distances, when infected but asymptomatic persons travel and carry infection to others over wide distances.
Maíra Aguiar   +11 more
core   +1 more source

Fractional vector calculus and fractional Maxwell’s equations [PDF]

open access: yesAnnals of Physics, 2008
The theory of derivatives and integrals of non-integer order goes back to Leibniz, Liouville, Grunwald, Letnikov and Riemann. The history of fractional vector calculus (FVC) has only 10 years. The main approaches to formulate a FVC, which are used in the physics during the past few years, will be briefly described in this paper.
openaire   +3 more sources

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Barrier Options and a Reflection Principle of the Fractional Brownian Motion [PDF]

open access: yes
The purpose of this paper is to obtain the price of the barrier options in a fractional Brownian motion environment in the special case of zero interest rate. As a consequence we derive a reflection principle for the fractional Brownian motion.fractional
Cipian Necula
core  

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Necessary optimality conditions for fractional action-like problems with intrinsic and observer times

open access: yes, 2008
We prove higher-order Euler-Lagrange and DuBois-Reymond stationary conditions to fractional action-like variational problems.
Frederico, G.S.F., Torres, D.F.M.
core  

Fractional Calculus: Quo Vadimus? (Where Are We Going?)

open access: yes, 2015
Discussions under this title were held during a special session in frames of the International Conference “Fractional Differentiation and Applications” (ICFDA ’14) held in Catania (Italy), 23-25 June 2014, see details at http://www.icfda14.dieei.unict.it/
Kiryakova, V.   +5 more
core   +1 more source

Professor Rudolf Gorenflo and his Contribution to Fractional Calculus [PDF]

open access: yes, 2011
MSC 2010: 26A33 Dedicated to Professor Rudolf Gorenflo on the occasion of his 80th anniversaryThis paper presents a brief overview of the life story and professional career of Prof. R.
Luchko, Yury   +7 more
core   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy